(a) The board shall adopt guidelines for the prescription of opioid antagonists.
(b) The guidelines must address:
(1) prescribing an opioid antagonist to a patient to whom an opioid medication is also prescribed; and
(2) identifying patients at risk of an opioid-related drug overdose and prescribing an opioid antagonist to that patient or to a person in a position to administer the opioid antagonist to that patient.
(c) In adopting guidelines under this section, the board:
(1) shall consult with the Texas State Board of Pharmacy;
(2) shall consult materials published by the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services; and
(3) may consult other appropriate materials, including medical journals subject to peer review and publications by medical professional associations.
(c) In adopting guidelines under this section, the board:
(1) shall consult materials published by the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services; and
(2) may consult other appropriate materials, including medical journals subject to peer review and publications by medical professional associations.